- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
Basel Medical Group
Market Cap: US$7.5m
Provides healthcare services in Singapore.
BMGL
US$4.80
7D
-2.6%
1Y
-79.6%
Alzamend Neuro
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$1.60
7D
5.3%
1Y
-34.4%
BioElectronics
Market Cap: US$7.4m
An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.
BIEL
US$0.0003
7D
0%
1Y
50.0%
Thalia Therapeutics
Market Cap: UK£5.4m
A biotechnology company, develops and delivers RNA-based therapeutics and technologies in oncology and cardiovascular disease in the United Kingdom.
THAT
UK£0.0065
7D
0%
1Y
52.9%
Acurx Pharmaceuticals
Market Cap: US$7.4m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$1.41
7D
-2.1%
1Y
-72.4%
Cuprina Holdings (Cayman)
Market Cap: US$7.3m
A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
CUPR
US$2.92
7D
-1.7%
1Y
-62.8%
InnoCan Pharma
Market Cap: CA$10.1m
Operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally.
INNO
CA$2.20
7D
-4.3%
1Y
-83.9%
Curanex Pharmaceuticals
Market Cap: US$7.3m
A developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases.
CURX
US$4.75
7D
7.0%
1Y
-94.1%
Bolt Biotherapeutics
Market Cap: US$7.2m
A clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer.
BOLT
US$3.85
7D
21.2%
1Y
-27.9%
Pomdoctor
Market Cap: US$7.2m
Through its subsidiaries, offers an online B2C portal to sell pharmaceutical products.
POM
US$0.93
7D
-1.5%
1Y
n/a
Oxford BioDynamics
Market Cap: UK£5.3m
Operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.
OBD
UK£0.0012
7D
-6.9%
1Y
-74.3%
Apimeds Pharmaceuticals US
Market Cap: US$7.2m
Provides digital asset treasury solutions in bitcoin treasury infrastructure.
APUS
US$4.97
7D
24.3%
1Y
n/a
Curative Biotechnology
Market Cap: US$7.2m
A biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications.
CUBT
US$0.95
7D
5.5%
1Y
-46.8%
Avant Brands
Market Cap: CA$9.8m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.60
7D
-3.2%
1Y
-29.4%
enVVeno Medical
Market Cap: US$7.1m
A medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States.
NVNO
US$10.80
7D
-2.1%
1Y
-65.5%
Marvel Biosciences
Market Cap: CA$9.8m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.15
7D
-6.3%
1Y
-28.6%
Verici Dx
Market Cap: UK£5.1m
Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.
VRCI
UK£0.0022
7D
0%
1Y
-57.1%
Noveris Health Sciences
Market Cap: CA$9.7m
A biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality.
NVRS
CA$0.17
7D
-5.6%
1Y
-66.0%
Nexalin Technology
Market Cap: US$7.0m
A medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China.
NXL
US$0.32
7D
-4.4%
1Y
-62.4%
Eagle Pharmaceuticals
Market Cap: US$6.9m
A pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.
EGRX
US$0.53
7D
-10.9%
1Y
-83.4%
Rua Bioscience
Market Cap: NZ$11.5m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.034
7D
3.0%
1Y
-41.4%
ECS Botanics Holdings
Market Cap: AU$9.6m
Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally.
ECS
AU$0.006
7D
20.0%
1Y
-25.0%
ENDRA Life Sciences
Market Cap: US$6.8m
Develops technologies to improve the capabilities of clinical diagnostic ultrasound.
NDRA
US$4.75
7D
5.3%
1Y
16.1%
CurveBeam AI
Market Cap: AU$9.6m
Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia.
CVB
AU$0.02
7D
5.3%
1Y
-85.7%
Cardiac Biotech Solutions
Market Cap: US$6.8m
Through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally.
CBSC
US$0.04
7D
22.4%
1Y
2.6%
Adaptimmune Therapeutics
Market Cap: US$6.8m
Engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom.
ADAP.Y
US$0.025
7D
-2.7%
1Y
-56.9%
AquaBounty Technologies
Market Cap: US$6.7m
Operates as a land-based aquaculture company.
AQB
US$1.33
7D
-3.6%
1Y
74.1%
BioCorRx
Market Cap: US$6.6m
Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.
BICX
US$0.22
7D
-7.1%
1Y
-33.9%
Vectus Biosystems
Market Cap: AU$9.2m
Engages in the medical research and development activities in Australia.
VBS
AU$0.15
7D
-11.8%
1Y
87.5%
20/20 Biolabs
Market Cap: US$6.6m
Develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
AIDX
US$0.53
7D
2.3%
1Y
n/a
Dermata Therapeutics
Market Cap: US$6.6m
Engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
DRMA
US$1.72
7D
20.3%
1Y
-68.7%
Invex Therapeutics
Market Cap: AU$9.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.13
7D
18.2%
1Y
34.0%
SenesTech
Market Cap: US$6.5m
Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
SNES
US$1.19
7D
-7.8%
1Y
-74.9%
Kelyniam Global
Market Cap: US$6.4m
A medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.
KLYG
US$0.13
7D
-11.7%
1Y
95.4%
Sonoma Pharmaceuticals
Market Cap: US$6.4m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$1.35
7D
3.8%
1Y
-72.0%
Adheris Health
Market Cap: AU$8.9m
Provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom.
AHE
AU$0.014
7D
-6.7%
1Y
-73.6%